Back
Compass Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
79
CMPX
Compass Therapeutics, Inc.
Last Price:
$6.29
Seasonality Move:
-7.27%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and CMPX is experiencing selling pressure, which indicates risk of future bearish movement.
Compass Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.43 | Sell |
| 20-day SMA: | 6.27 | Buy |
| 50-day SMA: | 5.67 | Buy |
| 200-day SMA: | 3.84 | Buy |
| 8-day EMA: | 6.39 | Sell |
| 20-day EMA: | 6.22 | Buy |
| 50-day EMA: | 5.73 | Buy |
| 200-day EMA: | 4.23 | Buy |
Compass Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.24 | Buy |
| Relative Strength Index (14 RSI): | 54.31 | Buy |
| Chaikin Money Flow: | -1613676 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.74 - 6.52) | Buy |
| Bollinger Bands (100): | (4.05 - 5.87) | Buy |
Compass Therapeutics, Inc. Technical Analysis
| Feb 2 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 9 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Compass Therapeutics, Inc. Stock
Is Compass Therapeutics, Inc. Stock a Buy?
-
Compass Therapeutics, Inc. share price is 6.28 while CMPX 8-day simple moving average is 6.43, which is a Sell signal.
-
The stock price of CMPX is 6.28 while Compass Therapeutics, Inc. 20-day SMA is 6.27, which makes it a Buy.
-
Compass Therapeutics, Inc. 50-day simple moving average is 5.67 while CMPX share price is 6.28, making it a Buy technically.
-
CMPX stock price is 6.28 and Compass Therapeutics, Inc. 200-day simple moving average is 3.84, creating a Buy signal.
CMPX Technical Analysis vs Fundamental Analysis
Buy
79
Compass Therapeutics, Inc. (CMPX)
is a Buy
Is Compass Therapeutics, Inc. a Buy or a Sell?
-
Compass Therapeutics, Inc. stock is rated a BuyThe current Compass Therapeutics, Inc. [CMPX] share price is $6.28. The Score for CMPX is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
Compass Therapeutics, Inc. Stock Info
Market Cap:
1.1B
Price in USD:
6.28
Share Volume:
2.5M
Compass Therapeutics, Inc. 52-Week Range
52-Week High:
6.88
52-Week Low:
1.33
Buy
79
Compass Therapeutics, Inc. (CMPX)
is a Buy
Compass Therapeutics, Inc. Share Price Forecast
-
What is the Compass Therapeutics, Inc. stock price today?The Compass Therapeutics, Inc. stock price is 6.28 USD today.
-
Will CMPX stock go up or go down?Compass Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Compass Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Compass Therapeutics, Inc. is not overvalued.
Is Compass Therapeutics, Inc. Stock a Buy?
-
Compass Therapeutics, Inc. share price is 6.28 while CMPX 8-day exponential moving average is 6.39, which is a Sell signal.
-
The stock price of CMPX is 6.28 while Compass Therapeutics, Inc. 20-day EMA is 6.22, which makes it a Buy.
-
Compass Therapeutics, Inc. 50-day exponential moving average is 5.73 while CMPX share price is 6.28, making it a Buy technically.
-
CMPX stock price is 6.28 and Compass Therapeutics, Inc. 200-day simple moving average is 4.23, creating a Buy signal.
Fundamental Analysis of Compass Therapeutics, Inc.
Is Compass Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and a decrease next year of $0.06 per share.
Technical Analysis of Compass Therapeutics, Inc.
Should I short Compass Therapeutics, Inc. stock?
-
CMPX Moving Average Covergence Divergence (MACD) indicator is 0.24, suggesting Compass Therapeutics, Inc. is a Buy
-
Compass Therapeutics, Inc. Relative Strength Index (RSI) is 54.31, which suggest Compass Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Compass Therapeutics, Inc. is (5.74 - 6.52), which suggest Compass Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Compass Therapeutics, Inc. is (4.05 - 5.87), which suggest Compass Therapeutics, Inc. is a Buy
* Compass Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.